Vidwan-ID : 128218



  • Prof Debasis Manna

  • Professor
  • Indian Institute of Technology Guwahati
Publications 2007 - 2024

Publications

  • 66
    Journal Articles
  • 1
    Conference
    Proceedings
  • 1
    Review
  • 4
    Projects
  • 5
  • 4
  • 1
  • 59

Citations / H-Index

1094 Citations
18 h-index
1214 Citations

Altmetrics

10
8
53
163
2

Google Scholar

Co-author Network


Expertise

Applied Chemistry

Ion transport, Liposomal drug delivery, Drug discovery and immunotherapy

Personal Information

Prof Debasis Manna

Male
Indian Institute of Technology Guwahati
Guwahati, Assam, India - 781039


Experience

  • Professor

    Department of Chemistry

    Indian Institute of Technology Guwahati


Qualification

  • Ph. D

    University of Illinois at Chicago

  • M.Sc.

    Indian Institute of Technology Bombay

  • B.Sc.

    Calcutta University

  • Ph.D


Honours and Awards

2010

Young Investigators Award (RGYI Scheme)

Department of Biotechnology (DBT), New Delhi, India

2010

Young Scientist Research Award (YSRA)

Board of Research in Nuclear Sciences (BRNS), Mumbai, India

2006

Research Assistant (NIH) and Teaching Assistant (Univ of Illinois at Chicago) fellowship

Univ of Illinois at Chicago

Read More
2010

Young Investigators Award (RGYI Scheme)

Department of Biotechnology (DBT), New Delhi, India

2010

Young Scientist Research Award (YSRA)

Board of Research in Nuclear Sciences (BRNS), Mumbai, India

2006

Research Assistant (NIH) and Teaching Assistant (Univ of Illinois at Chicago) fellowship

Univ of Illinois at Chicago

2000

Certificate of Excellence for First Class in B.Sc. (Chemistry)

Ramakrishna Mission Residential College, University of Calcutta, India

Read Less

Doctoral Theses Guided

2020

Development of Synthetic Organic-Carriers for Drug Molecules and Chloride Ion

Dr. Abhishek Saha, Indian Institute of Technology Guwahati

2019

Synthsis of N-Heterocylces as Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors

Dr. Subhankar Panda, Indian Institute of Technology Guwahati

2018

Activity Studies of Indoleamine 2,3-dioxygenase 1 Enzyme

Dr. Ashalata Roy, Indian Institute of Technology Guwahati

Read More
2020

Development of Synthetic Organic-Carriers for Drug Molecules and Chloride Ion

Dr. Abhishek Saha, Indian Institute of Technology Guwahati

2019

Synthsis of N-Heterocylces as Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors

Dr. Subhankar Panda, Indian Institute of Technology Guwahati

2018

Activity Studies of Indoleamine 2,3-dioxygenase 1 Enzyme

Dr. Ashalata Roy, Indian Institute of Technology Guwahati

2017

Design and Synthesis of Indoleamine 2,3-Dioxygenase 1 Inhibitors

Dr. Saurav Paul, Indian Institute of Technology Guwahati

2016

Membrane Binding Mechanism of Phosphoinositide Interacting Domains and Development of Their Inhibitors

Dr. Sukhamoy Gorai, Indian Institute of Technology Guwahati

2016

C1 domain: Investigation of DAG/Phorbol ester binding properties and development of ligands

Dr. Rituparna Borah , Indian Institute of Technology Guwahati

2014

Design and Synthesis of Esters as Protein Kinase C (PKC)-C1 domain regulators

Dr. Narsimha Mamidi, Indian Institute of Technology Guwahati

Read Less

Membership In Professional Bodies

2018

CHEMICAL RESEARCH SOCIETY OF INDIA

CRSI Life membership

2018

Indian Society of Chemists and Biologists

ISCB Life membership

2018

CHEMICAL RESEARCH SOCIETY OF INDIA

CRSI Life membership

2018

Indian Society of Chemists and Biologists

ISCB Life membership

Read Less

Research Projects

Cancer Immunotherapy: Mechanism-Based Design of Potent Inhibitor for Indoleamine 2,3-Dioxygenase-1

Funding Agency : Science and Engineering Research Board, Govt. of India

Development of Novel Inhibitors of AKT: An Unorthodox Approach Targeting the Pleckstrin Homology Domain

Funding Agency : Department of Biotechnology, Govt. of India

Development of Nitrobenzofurazan, Indazole, Triazole and Triazine derivatives as Potent and Selective Inhibitors of Indoleamine 2,3-Dioxygenase

Funding Agency : DST, India

Read More

Cancer Immunotherapy: Mechanism-Based Design of Potent Inhibitor for Indoleamine 2,3-Dioxygenase-1

Funding Agency : Science and Engineering Research Board, Govt. of India

Development of Novel Inhibitors of AKT: An Unorthodox Approach Targeting the Pleckstrin Homology Domain

Funding Agency : Department of Biotechnology, Govt. of India

Development of Nitrobenzofurazan, Indazole, Triazole and Triazine derivatives as Potent and Selective Inhibitors of Indoleamine 2,3-Dioxygenase

Funding Agency : DST, India

Design, Synthesis and Biological Activities of Protein Kinase C Activators

Funding Agency : CSIR, India

Read Less

Patents



Read Less